Surveillance of antimicrobial resistance among Enterococcus Faecium and Enterococcus Faecalis isolated from human (clinical/commensal), food animal, meat and environmental samples

Enterococcus and Safety

Volumn , Issue , 2012, Pages 155-198

  Werner, Guido ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880720463     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (308)

1. Aarestrup FM, Butaye P, Witte W: Nonhuman reservoirs of enterococci. In The enterococci: Pathogenesis, molecular biology, and antibiotic resistance. 1 edition. Edited by Edited by Gilmore MS. Washington, D.C.: ASM Press; 2002:55-100.
2. Lundgren JG, Lehman RM: Bacterial gut symbionts contribute to seed digestion in an omnivorous beetle. PLoS ONE 2010, 5:e10831.
3. Ferreira A, Quecine MC, Lacava PT, Oda S, Azevedo JL, Araujo WL: Diversity of endophytic bacteria from Eucalyptus species seeds and colonization of seedlings by Pantoea agglomerans. FEMS Microbiol Lett 2008, 287:8-14.
4. Garcia S, Wade B, Bauer C, Craig C, Nakaoka K, Lorowitz W: The effect of wastewater treatment on antibiotic resistance in Escherichia coli and Enterococcus sp. Water Environ Res 2007, 79:2387-2395.
5. Martins da Costa PM, Vaz-Pires PM, Bernardo FM: Antibiotic resistance of Enterococcus spp. isolated from wastewater and sludge of poultry slaughterhouses. J Environ Sci Health B 2006, 41:1393-1403.
6. Martins da CP, Vaz-Pires P, Bernardo F: Antimicrobial resistance in Enterococcus spp. isolated in inflow, effluent and sludge from municipal sewage water treatment plants. Water Res 2006, 40:1735-1740.
7. Foulquie Moreno MR, Sarantinopoulos P, Tsakalidou E, De VL: The role and application of enterococci in food and health. Int J Food Microbiol 2006, 106:1-24.
8. Giraffa G: Functionality of enterococci in dairy products. Int J Food Microbiol 2003, 88:215-222.
9. Molinos AC, Abriouel H, Ben ON, Lucas R, Valdivia E, Galvez A: Inactivation of Listeria monocytogenes in raw fruits by enterocin AS-48. J Food Prot 2008, 71:2460-2467.
10. Arias CA, Murray BE: Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther 2008, 6:637-655.
11. Murray BE: The life and times of the Enterococcus. Clin Microbiol Rev 1990, 3:46-65.
12. Rice LB: Antimicrobial resistance in gram-positive bacteria. Am J Infect Control 2006, 34:S11-S19.
13. Malami PN, Kauffman CA, Zervos MJ: Enterococcal disease, epidemiology, and treatment. In The enterococci: Pathogenesis, molecular biology, and antibiotic resistance. 1 edition. Edited by Edited by Gilmore MS. Washington, D.C.: ASM Press; 2002:385-408.
14. Contreras GA, DiazGranados CA, Cortes L, Reyes J, Vanegas S, Panesso D, Rincon S, Diaz L, Prada G, Murray BE et al.: Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci. J Hosp Infect 2008, 70:346-352.
15. Shirano M, Takakura S, Yamamoto M, Matsumura Y, Matsushima A, Nagao M, Fujihara N, Saito T, Ito Y, Iinuma Y et al.: Regional spread of vanA-or vanB-positive Enterococcus gallinarum in hospitals and long-term care facilities in Kyoto prefecture, Japan. Epidemiol Infect 2010,1-7.
16. Kawalec M, Kedzierska J, Gajda A, Sadowy E, Wegrzyn J, Naser S, Skotnicki AB, Gniadkowski M, Hryniewicz W: Hospital outbreak of vancomycin-resistant enterococci caused by a single clone of Enterococcus raffinosus and several clones of Enterococcus faecium. Clinical Microbiology and Infection 2007, 13:893-901.
17. Samuel J, Coutinho H, Galloway A, Rennison C, Kaufmann ME, Woodford N: Glycopeptide-resistant Enterococcus raffinosus in a haematology unit: an unusual cause of a nosocomial outbreak. J Hosp Infect 2008, 70:294-296.
18. Devriese LA, Pot B, Collins MD: Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups. J Appl Bacteriol 1993, 75:399-408.
19. Facklam RR, Carvalho MdGS, Teixeira LM: History, taxonomy, biochemical characteristics, and antibiotic susceptibility testing of enterococci. In The enterococci: Pathogenesis, molecular biology, and antibiotic resistance. 1 edition. Edited by Edited by Gilmore MS. Washington, D.C.: ASM Press; 2002:1-54.
20. Klare I, Werner G, Witte W: Enterococci. Habitats, infections, virulence factors, resistances to antibiotics, transfer of resistance determinants. Contrib Microbiol 2001, 8:108-122.
21. Klare I, Konstabel C, Badstübner D, Werner G, Witte W: Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int J Food Microbiol 2003, 88:269-290.
22. Murray BE: Vancomycin-resistant enterococcal infections. N Engl J Med 2000, 342:710-721.
23. Singh KV, Weinstock GM, Murray BE: An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristindalfopristin. Antimicrob Agents Chemother 2002, 46:1845-1850.
24. Singh KV, Murray BE: Differences in the Enterococcus faecalis lsa locus that influence susceptibility to quinupristin-dalfopristin and clindamycin. Antimicrob Agents Chemother 2005, 49:32-39.
25. Arsene S, Leclercq R: Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones. Antimicrob Agents Chemother 2007, 51:3254-3258.
26. Rodriguez-Martinez JM, Velasco C, Briales A, Garcia I, Conejo MC, Pascual A: Qnrlike pentapeptide repeat proteins in gram-positive bacteria. J Antimicrob Chemother 2008, 61:1240-1243.
27. Tenover FC, McDonald LC: Vancomycin-resistant staphylococci and enterococci: epidemiology and control. Curr Opin Infect Dis 2005, 18:300-305.
28. Nordmann P, Naas T, Fortineau N, Poirel L: Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr Opin Microbiol 2007, 10:436-440.
29. McBride SM, Fischetti VA, Leblanc DJ, Moellering RC, Jr., Gilmore MS: Genetic diversity among Enterococcus faecalis. PLoS ONE 2007, 2:e582.
30. Ruiz-Garbajosa P, Bonten MJ, Robinson DA, Top J, Nallapareddy SR, Torres C, Coque TM, Canton R, Baquero F, Murray BE et al.: Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol 2006, 44:2220-2228.
31. Nallapareddy SR, Wenxiang H, Weinstock GM, Murray BE: Molecular characterization of a widespread, pathogenic, and antibiotic resistance-receptive Enterococcus faecalis lineage and dissemination of its putative pathogenicity island. J Bacteriol 2005, 187:5709-5718.
32. Jureen R, Mohn SC, Harthug S, Haarr L, Langeland N: Role of penicillin-binding protein 5 C-terminal amino acid substitutions in conferring ampicillin resistance in Norwegian clinical strains of Enterococcus faecium. APMIS 2004, 112:291-298.
33. Rice LB, Bellais S, Carias LL, Hutton-Thomas R, Bonomo RA, Caspers P, Page MGP, Gutmann L: Impact of specific pbp 5 mutations on expression of {beta}-lactam resistance in Enterococcus faecium. Antimicrob Agents Chemother 2004, 48:3028-3032.
34. Rice LB, Carias LL, Rudin S, Hutton R, Marshall S, Hassan M, Josseaume N, Dubost L, Marie A, Arthur M: Role of class A penicillin-binding proteins in the expression of beta-lactam resistance in Enterococcus faecium. J Bacteriol 2009, 191:3649-3656.
35. Carias LL, Rudin SD, Donskey CJ, Rice LB: Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 1998, 180:4426-4434.
36. Valdezate S, Labayru C, Navarro A, Mantecon MA, Ortega M, Coque TM, Garcia M, Saez-Nieto JA: Large clonal outbreak of multidrug-resistant CC17 ST17 Enterococcus faecium containing Tn5382 in a Spanish hospital. J Antimicrob Chemother 2009, 63:17-20.
37. Horodniceanu T, Bougueleret L, El-Solh N, Bieth G, Delbos F: High-level, plasmidborne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother 1979, 16:686-689.
38. Casetta A, Hoi AB, de CG, Horaud T: Diversity of structures carrying the high-level gentamicin resistance gene (aac6-aph2) in Enterococcus faecalis strains isolated in France. Antimicrob Agents Chemother 1998, 42:2889-2892.
39. Klibi N, Ben SK, Masmoudi A, Gharbi S, Ruiz-Larrea F, Fendri C, Boudabous A, Torres C: Diversity of structures carrying the aac(6')-aph(2") gene in clinical Enterococcus faecalis and Enterococcus faecium strains isolated in Tunisia. J Chemother 2006, 18:353-359.
40. Tanimoto K, Ike Y: Complete nucleotide sequencing and analysis of the 65-kb highly conjugative Enterococcus faecium plasmid pMG1: identification of the transfer-related region and the minimum region required for replication. FEMS Microbiol Lett 2008, 288:186-195.
41. Hallgren A, Saeedi B, Nilsson M, Monstein HJ, Isaksson B, Hanberger H, Nilsson LE: Genetic relatedness among Enterococcus faecalis with transposon-mediated high-level gentamicin resistance in Swedish intensive care units. J Antimicrob Chemother 2003, 52:162-167.
42. Mahbub AM, Kobayashi N, Ishino M, Sumi A, Kobayashi K, Uehara N, Watanabe N: Detection of a novel aph(2") allele (aph[2“]-Ie) conferring high-level gentamicin resistance and a spectinomycin resistance gene ant(9)-Ia (aad 9) in clinical isolates of enterococci. Microb Drug Resist 2005, 11:239-247.
43. Jackson CR, Fedorka-Cray PJ, Barrett JB, Ladely SR: Genetic relatedness of high-level aminoglycoside-resistant enterococci isolated from poultry carcasses. Avian Dis 2004, 48:100-107.
44. Zarrilli R, Tripodi MF, Di PA, Fortunato R, Bagattini M, Crispino M, Florio A, Triassi M, Utili R: Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy. J Antimicrob Chemother 2005, 56:827-835.
45. Bischoff K, Jacob J: [The sat4 streptothricin acetyltransferase gene of Campylobacter coli: its distribution in the environment and use as epidemiological marker]. Zentralbl Hyg Umweltmed 1996, 198:241-257.
46. Jacob J, Evers S, Bischoff K, Carlier C, Courvalin P: Characterization of the sat4 gene encoding a streptothricin acetyltransferase in Campylobacter coli BE/G4. FEMS Microbiol Lett 1994, 120:13-17.
47. Derbise A, Dyke KG, El Solh N: Characterization of a Staphylococcus aureus transposon, Tn5405, located within Tn5404 and carrying the aminoglycoside resistance genes, aphA-3 and aadE. Plasmid 1996, 35:174-188.
48. Derbise A, de CG, El SN: Nucleotide sequence of the Staphylococcus aureus transposon, Tn5405, carrying aminoglycosides resistance genes. J Basic Microbiol 1997, 37:379-384.
49. Perreten V, Kadlec K, Schwarz S, Gronlund AU, Finn M, Greko C, Moodley A, Kania SA, Frank LA, Bemis DA et al.: Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother 2010, 65:1145-1154.
50. Werner G, Hildebrandt B, Witte W: Aminoglycoside-streptothricin resistance gene cluster aadE-sat4-aphA-3 disseminated among multiresistant isolates of Enterococcus faecium. Antimicrob Agents Chemother 2001, 45:3267-3269.
51. Werner G, Hildebrandt B, Witte W: Linkage of erm(B) and aadE-sat4-aphA-3 in multiple-resistant Enterococcus faecium isolates of different ecological origins. Microb Drug Resist 2003, 9 Suppl 1:S9-16.
52. Schwarz FV, Perreten V, Teuber M: Sequence of the 50-kb conjugative multiresistance plasmid pRE25 from Enterococcus faecalis RE25. Plasmid 2001, 46:170-187.
53. Hooper DC: Fluoroquinolone resistance among Gram-positive cocci. The Lancet Infectious Diseases 2002, 2:530-538.
54. Jacoby GA: Mechanisms of resistance to quinolones. Clin Infect Dis 2005, 41 Suppl 2:S120-S126.
55. Onodera Y, Okuda J, Tanaka M, Sato K: Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis. Antimicrob Agents Chemother 2002, 46:1800-1804.
56. Oyamada Y, Ito H, Inoue M, Yamagishi Ji: Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis. J Med Microbiol 2006, 55:1395-1401.
57. Oyamada Y, Ito H, Fujimoto K, Asada R, Niga T, Okamoto R, Inoue M, Yamagishi Ji: Combination of known and unknown mechanisms confers high-level resistance to fluoroquinolones in Enterococcus faecium. J Med Microbiol 2006, 55:729-736.
58. Leavis HL, Willems RJL, Top J, Bonten MJM: High-Level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. J Clin Microbiol 2006, 44:1059-1064.
59. Werner G, Fleige C, Ewert B, Laverde-Gomez JA, Klare I, Witte W: High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17). Int J Antimicrob Agents 2010, 35:119-125.
60. Woodford N, Reynolds R, Turton J, Scott F, Sinclair A, Williams A, Livermore D: Two widely disseminated strains of Enterococcus faecalis highly resistant to gentamicin and ciprofloxacin from bacteraemias in the UK and Ireland. J Antimicrob Chemother 2003, 52:711-714.
61. Leclercq R, Derlot E, Duval J, Courvalin P: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988, 319:157-161.
62. Leclercq R, Derlot E, Weber M, Duval J, Courvalin P: Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1989, 33:10-15.
63. Sahm DF, Kissinger J, Gilmore MS, Murray PR, Mulder R, Solliday J, Clarke B: In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1989, 33:1588-1591.
64. Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF et al.: Role of mobile DNA in the evolution of vancomycinresistant Enterococcus faecalis. Science 2003, 299:2071-2074.
65. Courvalin P: Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006, 42 Suppl 1:S25-S34.
66. Werner G, Strommenger B, Witte W: Acquired vancomycin resistance in clinically relevant pathogens. Future Microbiology 2008, 3:547-562.
67. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson KG, Leclercq R, Lester CH et al.: Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008, 13:pii19046.
68. Werner G, Dahl KH, Willems RJ: Composite elements encoding antibiotic resistance in Enterococcus faecium and Enterococcus faecalis. In Drug Resistance in Enterococci: Epidemiology and Molecular Markers. 1 edition. Edited by Edited by Kobayashi N. Fort P.O., Trivandrum, Kerala: Research Signpost; 2006:157-208.
69. Zheng B, Tomita H, Inoue T, Ike Y: Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2201, encoding erythromycin resistance and cytolysin (Hly/Bac). Antimicrob Agents Chemother 2009, 53:735-747.
70. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H: Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999, 43:2823-2830.
71. Novick RP, Murphy E: MLS-resistance determinants in Staphylococcus aureus and their molecular evolution. J Antimicrob Chemother 1985, 16 Suppl A:101-110.
72. Shaw JH, Clewell DB: Complete nucleotide sequence of macrolide-lincosamidestreptogramin B-resistance transposon Tn917 in Streptococcus faecalis. J Bacteriol 1985, 164:782-796.
73. Horinouchi S, Weisblum B: Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance. Proc Natl Acad Sci U S A 1980, 77:7079-7083.
74. Werckenthin C, Schwarz S, Westh H: Structural alterations in the translational attenuator of constitutively expressed ermC genes. Antimicrob Agents Chemother 1999, 43:1681-1685
75. Werckenthin C, Schwarz S: Molecular analysis of the translational attenuator of a constitutively expressed erm(A) gene from Staphylococcus intermedius. J Antimicrob Chemother 2000, 46:785-788.
76. Schmitz FJ, Witte W, Werner G, Petridou J, Fluit AC, Schwarz S: Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin/dalfopristin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides. J Antimicrob Chemother 2001, 48:939-941.
77. Martel A, Devriese LA, Decostere A, Haesebrouck F: Presence of macrolide resistance genes in streptococci and enterococci isolated from pigs and pork carcasses. Int J Food Microbiol 2003, 84:27-32.
78. Werner G, Klare I, Witte W: Molecular analysis of streptogramin resistance in enterococci. Int J Med Microbiol 2002, 292:81-94.
79. Werner G, Klare I, Heier H, Hinz KH, Bohme G, Wendt M, Witte W: Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany. Microb Drug Resist 2000, 6:37-47.
80. Rosato A, Vicarini H, Leclercq R: Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. J Antimicrob Chemother 1999, 43:559-562.
81. Min YH, Kwon AR, Yoon JM, Yoon EJ, Shim MJ, Choi EC: Molecular analysis of constitutive mutations in ermB and ermA selected in vitro from inducibly MLSBresistant enterococci. Arch Pharm Res 2008, 31:377-380.
82. Aarestrup FM: Characterization of glycopeptide-resistant enterococcus faecium (GRE) from broilers and pigs in Denmark: genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides. J Clin Microbiol 2000, 38:2774-2777.
83. Aarestrup FM, Agerso Y, Gerner-Smidt P, Madsen M, Jensen LB: Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagn Microbiol Infect Dis 2000, 37:127-137.
84. Manson JM, Keis S, Smith JMB, Cook GM: A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant enterococci isolated in New Zealand. Antimicrob Agents Chemother 2003, 47:204-210.
85. Werner G, Klare I, Witte W: Arrangement of the vanA gene cluster in enterococci of different ecological origin. FEMS Microbiol Lett 1997, 155:55-61.
86. Werner G, Klare I, Spencker FB, Witte W: Intra-hospital dissemination of quinupristin/dalfopristin-and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital. J Antimicrob Chemother 2003, 52:113-115.
87. Laverde-Gomez JA, van Schaik W, Freitas AR, Coque TM, Weaver K, Francia MV, Witte W, Werner G: A multiresistance megaplasmid bearing a hylEfm genomic island in hospital Enterococcus faecium isolates. International Journal of Medical Microbiology 2011, 301:541-554.
88. Borgen K, Sorum M, Wasteson Y, Kruse H, Oppegaard H: Genetic linkage between erm(B) and vanA in Enterococcus hirae of poultry origin. Microb Drug Resist 2002, 8:363-368.
89. Kerr ID, Reynolds ED, Cove JH: ABC proteins and antibiotic drug resistance: is it all about transport? Biochem Soc Trans 2005, 33:1000-1002.
90. Reynolds E, Ross JI, Cove JH: Msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters? Int J Antimicrob Agents 2003, 22:228-236.
91. Singh KV, Malathum K, Murray BE: Disruption of an Enterococcus faecium speciesspecific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob Agents Chemother 2001, 45:263-266.
92. Werner G, Hildebrandt B, Witte W: The newly described msrC gene is not equally distributed among all isolates of Enterococcus faecium. Antimicrob Agents Chemother 2001, 45:3672-3673.
93. Reynolds E, Cove JH: Enhanced resistance to erythromycin is conferred by the enterococcal msrC determinant in Staphylococcus aureus. J Antimicrob Chemother 2005, 55:260-264.
94. Werner G, Witte W: Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to Streptogramin A compounds. Antimicrob Agents Chemother 1999, 43:1813-1814.
95. Gfeller KY, Roth M, Meile L, Teuber M: Sequence and genetic organization of the 19.3-kb erythromycin-and dalfopristin-resistance plasmid pLME300 from Lactobacillus fermentum ROT1. Plasmid 2003, 50:190-201.
96. Jones RN, Deshpande LM: Are Enterococcus faecalis strains with vat(E) in poultry a reservoir for human streptogramin resistance? vat(E) occurrence in human enterococcal bloodstream infections in North America (SENTRY Antimicrobial Surveillance Program, 2002). Antimicrob Agents Chemother 2004, 48:360-361.
97. Simjee S, White DG, Wagner DD, Meng J, Qaiyumi S, Zhao S, McDermott PF: Identification of vat(E) in Enterococcus faecalis isolates from retail poultry and its transferability to Enterococcus faecium. Antimicrob Agents Chemother 2002, 46:3823-3828.
98. Jung YH, Shin ES, Kim O, Yoo JS, Lee KM, Yoo JI, Chung GT, Lee YS: Characterization of two newly identified genes, vgaD and vatG, conferring resistance to streptogramin A in Enterococcus faecium. Antimicrob Agents Chemother 2010, 54:4744-4749.
99. Roberts MC: Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 2005, 245:195-203.
100. Roberts AP, Johanesen PA, Lyras D, Mullany P, Rood JI: Comparison of Tn5397 from Clostridium difficile, Tn916 from Enterococcus faecalis and the CW459tet(M) element from Clostridium perfringens shows that they have similar conjugation regions but different insertion and excision modules. Microbiology 2001, 147:1243-1251.
101. Thal LA, Silverman J, Donabedian S, Zervos MJ: The effect of Tn916 insertions on contour-clamped homogeneous electrophoresis patterns of Enterococcus faecalis. J Clin Microbiol 1997, 35:969-972.
102. Clewell DB, Flannagan SE, Jaworski DD: Unconstrained bacterial promiscuity: the Tn916-Tn1545 family of conjugative transposons. Trends Microbiol 1995, 3:229-236.
103. Boguslawska J, Zycka-Krzesinska J, Wilcks A, Bardowski J: Intra-and interspecies conjugal transfer of Tn916-like elements from Lactococcus lactis in vitro and in vivo. Appl Environ Microbiol 2009, 75:6352-6360.
104. de Vries LE, Christensen H, Skov RL, Aarestrup FM, Agerso Y: Diversity of the tetracycline resistance gene tet(M) and identification of Tn916-and Tn5801-like (Tn6014) transposons in Staphylococcus aureus from humans and animals. J Antimicrob Chemother 2009, 64:490-500.
105. Agerso Y, Pedersen AG, Aarestrup FM: Identification of Tn5397-like and Tn916-like transposons and diversity of the tetracycline resistance gene tet(M) in enterococci from humans, pigs and poultry. J Antimicrob Chemother 2006, 57:832-839.
106. Rice LB, Carias LL, Marshall S, Rudin SD, Hutton-Thomas R: Tn5386, a novel Tn916-like mobile element in Enterococcus faecium D344R that interacts with Tn916 to yield a large genomic deletion. J Bacteriol 2005, 187:6668-6677.
107. Rice LB, Carias LL, Rudin S, Hutton RA, Marshall S: Multiple copies of functional, Tet(M)-encoding Tn916-like elements in a clinical Enterococcus faecium isolate. Plasmid 2010.
108. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL: The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 1998, 42:3251-3255.
109. Pai MP, Rodvold KA, Schreckenberger PC, Gonzales RD, Petrolatti JM, Quinn JP: Risk factors associated with the development of infection with linezolid-and vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2002, 35:1269-1272.
110. Prystowsky J, Siddiqui F, Chosay J, Shinabarger DL, Millichap J, Peterson LR, Noskin GA: Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 2001, 45:2154-2156.
111. Ruggero KA, Schroeder LK, Schreckenberger PC, Mankin AS, Quinn JP: Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs. Diagn Microbiol Infect Dis 2003, 47:511-513.
112. Seedat J, Zick G, Klare I, Konstabel C, Weiler N, Sahly H: Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection. Antimicrob Agents Chemother 2006, 50:4217-4219.
113. Bonora MG, Ligozzi M, Luzzani A, Solbiati M, Stepan E, Fontana R: Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment. Eur J Clin Microbiol Infect Dis 2006, 25:197-198.
114. Rahim S, Pillai SK, Gold HS, Venkataraman L, Inglima K, Press RA: Linezolidresistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin Infect Dis 2003, 36:E146-E148.
115. Qi C, Zheng X, Obias A, Scheetz MH, Malczynski M, Warren JR: Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis. J Clin Microbiol 2006, 44:1098-1100.
116. Sinclair A, Arnold C, Woodford N: Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci. Antimicrob Agents Chemother 2003, 47:3620-3622.
117. Werner G, Bartel M, Wellinghausen N, Essig A, Klare I, Witte W, Poppert S: Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization. J Clin Microbiol 2007, 45:3421-3423.
118. Werner G, Strommenger B, Klare I, Witte W: Molecular detection of linezolid resistance in Enterococcus faecium and Enterococcus faecalis by use of 5' nuclease real-time PCR compared to a modified classical approach. J Clin Microbiol 2004, 42:5327-5331.
119. Boumghar-Bourtchai L, Dhalluin A, Malbruny B, Galopin S, Leclercq R: Influence of recombination on development of mutational resistance to linezolid in Enterococcus faecalis JH2-2. Antimicrob Agents Chemother 2009, 53:4007-4009.
120. Bourgeois-Nicolaos N, Massias L, Couson B, Butel MJ, Andremont A, Doucet-Populaire F: Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J Infect Dis 2007, 195:1480-1488.
121. Lobritz M, Hutton-Thomas R, Marshall S, Rice LB: Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis. Antimicrob Agents Chemother 2003, 47:3318-3320.
122. Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB: Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002, 46:3334-3336.
123. Willems RJ, Top J, Smith DJ, Roper DI, North SE, Woodford N: Mutations in the DNA mismatch repair proteins MutS and MutL of oxazolidinone-resistant or-susceptible Enterococcus faecium. Antimicrob Agents Chemother 2003, 47:3061-3066.
124. Toh SM, Xiong L, Arias CA, Villegas MV, Lolans K, Quinn J, Mankin AS: Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Molecular Microbiology 2007, 64:1506-1514.
125. Manson JM, Hancock LE, Gilmore MS: Mechanism of chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule, antimicrobial resistance, and other traits. Proc Natl Acad Sci U S A 2010, 107:12269-12274.
126. Klare I, Heier H, Claus H, Witte W: Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett 1993, 106:23-29.
127. Torres C, Reguera JA, Sanmartin MJ, Perez-Diaz JC, Baquero F: vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother 1994, 33:553-561.
128. Bates J, Jordens JZ, Griffiths DT: Farm animals as a putative reservoir for vancomycinresistant enterococcal infection in man. J Antimicrob Chemother 1994, 34:507-514.
129. Bates J: Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. J Hosp Infect 1997, 37:89-101.
130. Klare I, Heier H, Claus H, Bohme G, Marin S, Seltmann G, Hakenbeck R, Antanassova V, Witte W: Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist 1995, 1:265-272.
131. Klare I, Heier H, Claus H, Reissbrodt R, Witte W: vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995, 125:165-171.
132. Klein G, Pack A, Reuter G: Antibiotic resistance patterns of enterococci and occurrence of vancomycin-resistant enterococci in raw minced beef and pork in Germany. Appl Environ Microbiol 1998, 64:1825-1830.
133. Kruse H, Johansen BK, Rorvik LM, Schaller G: The use of avoparcin as a growth promoter and the occurrence of vancomycin-resistant Enterococcus species in Norwegian poultry and swine production. Microb Drug Resist 1999, 5:135-139.
134. Simonsen GS, Andersen BM, Digranes A, Harthug S, Jacobsen T, Lingaas E, Natas OB, Olsvik O, Ringertz SH, Skulberg A et al.: Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. Scand J Infect Dis 1998, 30:465-468.
135. Schouten MA, Voss A, Hoogkamp-Korstanje JA: VRE and meat. Lancet 1997, 349:1258.
136. Klare I, Witte W: VRE: animal reservoirs and food. In Bacterial resistance to glycopeptides. Edited by Edited by Brun-Buisson C, Eliopoulos GM, Leclercq R. Paris: Flammarion Médecine-Sciences; 1998:83-93.
137. Stobberingh E, van Den BA, London N, Driessen C, Top J, Willems R: Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother 1999, 43:2215-2221.
138. Van Den Bogaard AE, Mertens P, London NH, Stobberingh EE: High prevalence of colonization with vancomycin-and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame? J Antimicrob Chemother 1997, 40:454-456.
139. Bonten MJ, Willems R, Weinstein RA: Vancomycin-resistant enterococci: why are they here, and where do they come from? The Lancet Infectious Diseases 2001, 1:314-325.
140. Woodford N, Adebiyi AM, Palepou MF, Cookson BD: Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother 1998, 42:502-508.
141. Aarestrup FM, Kruse H, Tast E, Hammerum AM, Jensen LB: Associations between the use of antimicrobial agents for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs in Denmark, Finland, and Norway. Microb Drug Resist 2000, 6:63-70.
142. Klare I, Badstubner D, Konstabel C, Bohme G, Claus H, Witte W: Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 1999, 5:45-52.
143. Borgen K, Simonsen GS, Sundsfjord A, Wasteson Y, Olsvik O, Kruse H: Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned. J Appl Microbiol 2000, 89:478-485.
144. Borgen K, Sorum M, Wasteson Y, Kruse H: VanA-type vancomycin-resistant enterococci (VRE) remain prevalent in poultry carcasses 3 years after avoparcin was banned. Int J Food Microbiol 2001, 64:89-94.
145. Ghidan A, Dobay O, Kaszanyitzky EJ, Samu P, Amyes SG, Nagy K, Rozgonyi F: Vancomycin resistant enterococci (VRE) still persist in slaughtered poultry in hungary 8 years after the ban on avoparcin. Acta Microbiol Immunol Hung 2008, 55:409-417.
146. Nilsson O, Greko C, Top J, Franklin A, Bengtsson B: Spread without known selective pressure of a vancomycin-resistant clone of Enterococcus faecium among broilers. J Antimicrob Chemother 2009, 63:868-872.
147. Sahlstrom L, Rehbinder V, Albihn A, Aspan A, Bengtsson B: Vancomycin resistant enterococci (VRE) in Swedish sewage sludge. Acta Vet Scand 2009, 51:24.
148. Fang H, Nord CE, Ullberg M: Screening for vancomycin-resistant enterococci: results of a survey in Stockholm. APMIS 2010, 118:413-417.
149. Soderblom T, Aspevall O, Erntell M, Hedin G, Heimer D, Hokeberg I, Kidd-Ljunggren K, Melhus A, Olsson-Liljequist B, Sjogren I et al.: Alarming spread of vancomycin resistant enterococci in Sweden since 2007. Euro Surveill 2010, 15:pii19620.
150. Lim SK, Kim TS, Lee HS, Nam HM, Joo YS, Koh HB: Persistence of vanA-type Enterococcus faecium in Korean livestock after ban on avoparcin. Microbial Drug Resistance 2006, 12:136-139.
151. Kojima A, Morioka A, Kijima M, Ishihara K, Asai T, Fujisawa T, Tamura Y, Takahashi T: Classification and antimicrobial susceptibilities of enterococcus species isolated from apparently healthy food-producing animals in Japan. Zoonoses Public Health 2010, 57:137-141.
152. Yoshimura H, Ishimaru M, Endoh YS, Suginaka M, Yamatani S: Isolation of glycopeptide-resistant enterococci from chicken in Japan. Antimicrob Agents Chemother 1998, 42:3333.
153. Lauderdale TL, Shiau YR, Wang HY, Lai JF, Huang IW, Chen PC, Chen HY, Lai SS, Liu YF, Ho M: Effect of banning vancomycin analogue avoparcin on vancomycinresistant enterococci in chicken farms in Taiwan. Environmental Microbiology 2007, 9:819-823.
154. Johnson PD, Ballard SA, Grabsch EA, Stinear TP, Seemann T, Young HL, Grayson ML, Howden BP: A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203. J Infect Dis 2010, 202:1278-1286.
155. Worth LJ, Slavin MA, Vankerckhoven V, Goossens H, Grabsch EA, Thursky KA: Virulence determinants in vancomycin-resistant Enterococcus faecium vanB: clonal distribution, prevalence and significance of esp and hyl in Australian patients with haematological disorders. J Hosp Infect 2008, 68:137-144.
156. Padiglione AA, Grabsch EA, Olden D, Hellard M, Sinclair MI, Fairley CK, Grayson ML: Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Infect Dis 2000, 6:534-536.
157. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE: Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996, 40:2605-2609.
158. Martone WJ: Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998, 19:539-545.
159. McDonald LC, Kuehnert MJ, Tenover FC, Jarvis WR: Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg Infect Dis 1997, 3:311-317.
160. Donabedian SM, Perri MB, Abdujamilova N, Gordoncillo MJ, Naqvi A, Reyes KC, Zervos MJ, Bartlett P: Characterization of vancomycin-resistant Enterococcus faecium isolated from swine in three Michigan counties. J Clin Microbiol 2010, 48:4156-4160.
161. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van VJ, Nathan C, Weinstein RA: The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998, 158:1127-1132.
162. Cetinkaya Y, Falk P, Mayhall CG: Vancomycin-resistant enterococci. Clin Microbiol Rev 2000, 13:686-707.
163. Panesso D, Reyes J, Rincon S, Diaz L, Galloway-Pena J, Zurita J, Carrillo C, Merentes A, Guzman M, Adachi JA et al.: Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals. J Clin Microbiol 2010, 48:1562-1569.
164. Witte W: Medical consequences of antibiotic use in agriculture. Science 1998, 279:996-997.
165. Witte W: Ecological impact of antibiotic use in animals on different complex microflora: environment. International Journal of Antimicrobial Agents 2000, 14:321-325.
166. Hsieh YC, Lee WS, Ou TY, Hsueh PR: Clonal spread of CC17 vancomycin-resistant Enterococcus faecium with multilocus sequence type 78 (ST78) and a novel ST444 in Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:25-30.
167. Zhu W, Murray PR, Huskins WC, Jernigan JA, McDonald LC, Clark NC, Anderson KF, McDougal LK, Hageman JC, Olsen-Rasmussen M et al.: Dissemination of an Enterococcus Inc18-like vanA plasmid, associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010, 54:4314-4320.
168. Klare I, Konstabel C, Mueller-Bertling S, Werner G, Strommenger B, Kettlitz C, Borgmann S, Schulte B, Jonas D, Serr A et al.: Spread of ampicillin/vancomycinresistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. European Journal of Clinical Microbiology & Infectious Diseases 2005, 24:815-825.
169. Werner G, Klare I, Fleige C, Witte W: Increasing rates of vancomycin resistance among Enterococcus faecium isolated from German hospitals between 2004 and 2006 are due to wide clonal dissemination of vancomycin-resistant enterococci and horizontal spread of vanA clusters. International Journal of Medical Microbiology 2007, 298:515-527.
170. Top J, Willems R, Blok H, de Regt M, Jalink K, Troelstra A, Goorhuis B, Bonten M: Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clinical Microbiology and Infection 2007, 13:316-319.
171. Bonora MG, Olioso D, Lo CG, Fontana R: Phylogenetic analysis of vancomycinresistant Enterococcus faecium genotypes associated with outbreaks or sporadic infections in Italy. Microb Drug Resist 2007, 13:171-177.
172. Borgmann S, Schulte B, Wolz C, Gruber H, Werner G, Goerke C, Klare I, Beyser K, Heeg P, Autenrieth IB: Discrimination between epidemic and non-epidemic glycopeptide-resistant E. faecium in a post-outbreak situation. J Hosp Infect 2007, 67:49-55.
173. Deplano A, Denis O, Nonhoff C, Rost F, Byl B, Jacobs F, Vankerckhoven V, Goossens H, Struelens MJ: Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control. J Antimicrob Chemother 2007, 60:849-854.
174. Hsieh YC, Ou TY, Teng SO, Lee WC, Lin YC, Wang JT, Chang SC, Lee WS: Vancomycin-resistant enterococci in a tertiary teaching hospital in Taiwan. J Microbiol Immunol Infect 2009, 42:63-68.
175. Yoo SJ, Sung H, Cho YU, Kim MN, Pai CH, Kim YS: Role of horizontal transfer of the transposon Tn1546 in the nosocomial spread of vanA vancomycin-resistant enterococci at a tertiary care hospital in Korea. Infect Control Hosp Epidemiol 2006, 27:1081-1087.
176. Top J, Banga NM, Hayes R, Willems RJ, Bonten MJ, Hayden MK: Comparison of multiple-locus variable-number tandem repeat analysis and pulsed-field gel electrophoresis in a setting of polyclonal endemicity of vancomycin-resistant Enterococcus faecium. Clin Microbiol Infect 2008, 14:363-369.
177. Garcia-Migura L, Hasman H, Svendsen C, Jensen LB: Relevance of hot spots in the evolution and transmission of Tn1546 in glycopeptide-resistant Enterococcus faecium (GREF) from broiler origin. J Antimicrob Chemother 2008, 62:681-687.
178. EARSS: EARSS Annual report 2008. EARSS Annual report 2008 2009, 10:1-180.
179. Nilsson O, Greko C, Bengtsson B: Environmental contamination by vancomycin resistant enterococci (VRE) in Swedish broiler production. Acta Vet Scand 2009, 51:49.
180. Sorum M, Johnsen PJ, Aasnes B, Rosvoll T, Kruse H, Sundsfjord A, Simonsen GS: Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin. Appl Environ Microbiol 2006, 72:516-521.
181. Lester CH, Sandvang D, Olsen SS, Schonheyder HC, Jarlov JO, Bangsborg J, Hansen DS, Jensen TG, Frimodt-Moller N, Hammerum AM: Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals. J Antimicrob Chemother 2008, 62:1203-1206.
182. Lester CH, Olsen SS, Schonheyder HC, Hansen DS, Tvede M, Holm A, Arpi M, Friis-Moller A, Jensen KT, Kemp M et al.: Typing of vancomycin-resistant enterococci obtained from patients at Danish hospitals and detection of a genomic island specific to CC17 Enterococcus faecium. Int J Antimicrob Agents 2009, 35:312-314.
183. Top J, Willems R, van d, V, Asbroek M, Bonten M: Emergence of clonal complex 17 Enterococcus faecium in The Netherlands. J Clin Microbiol 2008, 46:214-219.
184. Oteo J, Cuevas O, Navarro C, Aracil B, Campos J, on behalf of the Spanish Group of ‘The European Antimicrobial Resistance Surveillance System’ (EARSS): Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001-06, Spain): increasing ampicillin resistance in Enterococcus faecium. J Antimicrob Chemother 2007, 59:1044-1045.
185. Morris-Downes M, Smyth EG, Moore J, Thomas T, Fitzpatrick F, Walsh J, Caffrey V, Morris A, Foley S, Humphreys H: Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible. J Hosp Infect 2010, 75:228-233.
186. Novais C, Freitas AR, Sousa JC, Baquero F, Coque TM, Peixe LV: Diversity of Tn1546 and its role in the dissemination of vancomycin-resistant enterococci in Portugal. Antimicrob Agents Chemother 2008, 52:1001-1008.
187. Klare I, Werner G, Witte W: Enterococci with vancomycin resistance from German hospitals in 2008/2009 (German). Epidemiologisches Bulletin 2010, 2010:427-437.
188. Bourdon N, Berenger R, Lepoultier R, Mouet A, Lesteven C, Borgey F, Fines-Guyon M, Leclercq R, Cattoir V: Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay. Diagn Microbiol Infect Dis 2010, 67:291-293.
189. Stamper PD, Cai M, Lema C, Eskey K, Carroll KC: Comparison of the BD GeneOhm VanR Assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens. J Clin Microbiol 2007, 45:3360-3365.
190. Young HL, Ballard SA, Roffey P, Grayson ML: Direct detection of vanB2 using the Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage-sensitive but not specific. J Antimicrob Chemother 2007, 59:809-810.
191. Usacheva EA, Ginocchio CC, Morgan M, Maglanoc G, Mehta MS, Tremblay S, Karchmer TB, Peterson LR: Prospective, multicenter evaluation of the BD GeneOhm VanR assay for direct, rapid detection of vancomycin-resistant Enterococcus species in perianal and rectal specimens. Am J Clin Pathol 2010, 134:219-226.
192. Graham M, Ballard SA, Grabsch EA, Johnson PDR, Grayson ML: High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother 2008, 52:1195-1197.
193. Stamper PD, Shulder S, Bekalo P, Manandhar D, Ross TL, Speser S, Kingery J, Carroll KC: Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant Enterococci in rectal swab specimens. J Clin Microbiol 2010, 48:4294-4297.
194. Grabsch EA, Chua K, Xie S, Byrne J, Ballard SA, Ward PB, Grayson ML: Improved detection of vanB2-containing Enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J Clin Microbiol 2008, 46:1961-1964.
195. Grabsch EA, Ghaly-Derias S, Gao W, Howden BP: Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabs. J Clin Microbiol 2008, 46:4034-4036.
196. Pendle S, Jelfs P, Olma T, Su Y, Gilroy N, Gilbert GL: Difficulties in detection and identification of Enterococcus faecium with low-level inducible resistance to vancomycin, during a hospital outbreak. Clin Microbiol Infect 2008, 14:853-857.
197. Christiansen KJ, Tibbett PA, Beresford W, Pearman JW, Lee RC, Coombs GW, Kay ID, O’Brien FG, Palladino S, Douglas CR et al.: Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004, 25:384-390.
198. Pearman JW: 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci-from disaster to ongoing control. Journal of Hospital Infection 2006, 63:14-26.
199. Koh TH, Hsu LY, Chiu LL, Lin RVTP: Emergence of epidemic clones of vancomycinresistant Enterococcus faecium in Singapore. Journal of Hospital Infection 2006, 63:234-236.
200. Koh TH, Low BS, Leo N, Hsu LY, Lin RT, Krishnan P, Chan D, Nadarajah M, Toh SL, Ong KH: Molecular epidemiology of vancomycin-resistant enterococci in Singapore. Pathology 2009, 41:676-680.
201. Padiglione AA, Grabsch E, Wolfe R, Gibson K, Grayson ML: The prevalence of fecal colonization with VRE among residents of long-term-care facilities in Melbourne, Australia. Infect Control Hosp Epidemiol 2001, 22:576-578.
202. [201a] Werner G, Serr A, Schütt S, Schneider C, Klare I, Witte W, Scheuermann M, Torfs H, Wendt C: Comparison of direct cultivation on a selective solid medium, PCR from an enrichment broth and the BD GeneOhm™ VanR Assay for identification of vancomycin-resistant enterococci in screening specimens. Diagn. Microbiol. Inf. Dis. 2011, (in press) [10.1016/j.diagmicrobio.2011.04.004].
203. Manson JM, Keis S, Smith JM, Cook GM: Characterization of a vancomycin-resistant Enterococcus faecalis (VREF) isolate from a dog with mastitis: further evidence of a clonal lineage of VREF in New Zealand. J Clin Microbiol 2003, 41:3331-3333.
204. Park IJ, Lee WG, Shin JH, Lee KW, Woo GJ: VanB phenotype-vanA genotype Enterococcus faecium with heterogeneous expression of teicoplanin resistance. J Clin Microbiol 2008, 46:3091-3093.
205. Shin E, Hong H, Ike Y, Lee K, Park YH, Cho DT, Lee Y: VanB-vanA incongruent VRE isolated from animals and humans in 1999. J Microbiol 2006, 44:453-456.
206. Ko KS, Baek JY, Lee JY, Oh WS, Peck KR, Lee N, Lee WG, Lee K, Song JH: Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Korea. J Clin Microbiol 2005, 43:2303-2306.
207. Zheng B, Tomita H, Xiao YH, Ike Y: The first molecular analysis of clinical isolates of VanA-type vancomycin-resistant Enterococcus faecium strains in mainland China. Lett Appl Microbiol 2007, 45:307-312.
208. Zheng B, Tomita H, Xiao YH, Wang S, Li Y, Ike Y: Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from mainland China. J Clin Microbiol 2007, 45:2813-2818.
209. Zhu X, Zheng B, Wang S, Willems RJ, Xue F, Cao X, Li Y, Bo S, Liu J: Molecular characterisation of outbreak-related strains of vancomycin-resistant Enterococcus faecium from an intensive care unit in Beijing, China. J Hosp Infect 2009, 72:147-154.
210. Quinones Perez D: Epidemiology of antimicrobial resistance in Enterococcus spp. from Cuba and other Latin American countries. In Drug resistance of enterococci: Epidemiology and molecular mechanisms. 1 edition. Edited by Edited by Kobayashi N. Kerala, India: Research Signpost; 2006:1-20.
211. Sader HS, Moet GJ, Jones RN: Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals. J Chemother 2009, 21:611-620.
212. Lopez M, Hormazabal JC, Maldonado A, Saavedra G, Baquero F, Silva J, Torres C, Del CR: Clonal dissemination of Enterococcus faecalis ST201 and Enterococcus faecium CC17-ST64 containing Tn5382-vanB2 among 16 hospitals in Chile. Clin Microbiol Infect 2009, 15:586-588.
213. Karlowsky JA, Zhanel GG, Hoban DJ: Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals. Canadian VRE Surveillance Group. Diagn Microbiol Infect Dis 1999, 35:1-7.
214. Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA et al.: Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008, 52:1430-1437.
215. Zhanel GG, Harding GK, Rosser S, Hoban DJ, Karlowsky JA, Alfa M, Kabani A, Embil J, Gin A, Williams T et al.: Low prevalence of VRE gastrointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals. Can J Infect Dis 2000, 11:38-41.
216. Nichol KA, Sill M, Laing NM, Johnson JL, Hoban DJ, Zhanel GG: Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America. International Journal of Antimicrobial Agents 2006, 27:392-396.
217. Zhanel GG, DeCorby M, Adam H, Mulvey MR, McCracken M, Lagace-Wiens P, Nichol KA, Wierzbowski A, Baudry PJ, Tailor F et al.: Prevalence of antimicrobialresistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob Agents Chemother 2010, 54:4684-4693.
218. Zhanel GG, DeCorby M, Nichol KA, Baudry PJ, Karlowsky JA, Lagace-Wiens PR, McCracken M, Mulvey MR, Hoban DJ: Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum betalactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006). Can J Infect Dis Med Microbiol 2008, 19:243-249.
219. Van Caeseele P, Giercke S, Wylie J, Boyd D, Mulvey M, Amin S, Ofner-Agostini M: Identification of the first vancomycin-resistant Enterococcus faecalis harbouring vanE in Canada. Can Commun Dis Rep 2001, 27:101-104.
220. Boyd DA, Conly J, Dedier H, Peters G, Robertson L, Slater E, Mulvey MR: Molecular characterization of the vanD gene cluster and a novel insertion element in a vancomycin-resistant enterococcus isolated in Canada. J Clin Microbiol 2000, 38:2392-2394.
221. Boyd DA, Cabral T, Van CP, Wylie J, Mulvey MR: Molecular characterization of the vanE gene cluster in vancomycin-resistant Enterococcus faecalis N00-410 isolated in Canada. Antimicrob Agents Chemother 2002, 46:1977-1979.
222. Boyd DA, Kibsey P, Roscoe D, Mulvey MR: Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operon. J Antimicrob Chemother 2004, 54:680-683.
223. Boyd DA, Du T, Hizon R, Kaplen B, Murphy T, Tyler S, Brown S, Jamieson F, Weiss K, Mulvey MR: VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada. Antimicrob Agents Chemother 2006, 50:2217-2221.
224. Boyd DA, Willey BM, Fawcett D, Gillani N, Mulvey MR: Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother 2008, 52:2667-2672.
225. Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA: Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob 2004, 3:7.
226. Galloway-Pena JR, Nallapareddy SR, Arias CA, Eliopoulos GM, Murray BE: Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States. J Infect Dis 2009, 15:1566-1573.
227. Arias CA, Murray BE: Antibiotic-resistant bugs in the 21st century-a clinical superchallenge. N Engl J Med 2009, 360:439-443.
228. Willems RJ, van Schaik W.: Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol 2009, 4:1125-1135.
229. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN: Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007, 58:163-170.
230. Ramsey AM, Zilberberg MD: Secular trends of hospitalization with vancomycinresistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 2009, 30:184-186.
231. Agerso Y, Lester CH, Porsbo LJ, Orsted I, Emborg HD, Olsen KE, Jensen LB, Heuer OE, Frimodt-Moller N, Aarestrup FM et al.: Vancomycin-resistant Enterococcus faecalis isolates from a Danish patient and two healthy human volunteers are possibly related to isolates from imported turkey meat. J Antimicrob Chemother 2008, 62:844-845.
232. Larsen J, Schonheyder HC, Lester CH, Olsen SS, Porsbo LJ, Garcia-Migura L, Jensen LB, Bisgaard M, Hammerum AM: Porcine-origin gentamicin-resistant Enterococcus faecalis in Humans, Denmark. Emerg Infect Dis 2010, 16:682-684.
233. Manson JM, Smith JM, Cook GM: Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use. Appl Environ Microbiol 2004, 70:5764-5768.
234. Hammerum AM, Lester CH, Heuer OE: Antimicrobial-resistant enterococci in animals and meat: a human health hazard? Foodborne Pathog Dis 2010, 7:1137-1146.
235. Freitas AR, Francia MV, Peixe L, Novais C, Jensen L, Willems RJ, Baquero F, Coque TM: Plasmid characterisation of vancomycin-resistant Enterococcus faecium strains from different continents (1986-2007). 18th ECCMID conference 2008, Barcelona, 19.-22.04.2008:P2111.
236. Rosvoll TCS, Pedersen T, Sletvold H, Johnsen PJ, Sollid JE, Simonsen GS, Jensen LB, Nielsen KM, Sundsfjord A: PCR-based plasmid typing in Enterococcus faecium strains reveals widely distributed pRE25-, pRUM-, pIP501-and pHTbeta-related replicons associated with glycopeptide resistance and stabilizing toxin-antitoxin systems. FEMS Immunology and Medical Microbiology 2009, 58:254-268.
237. Sletvold H, Johnsen PJ, Simonsen GS, Aasnaes B, Sundsfjord A, Nielsen KM: Comparative DNA analysis of two vanA plasmids from Enterococcus faecium strains isolated from poultry and a poultry farmer in Norway. Antimicrob Agents Chemother 2007, 51:736-739.
238. Sletvold H, Johnsen PJ, Hamre I, Simonsen GS, Sundsfjord A, Nielsen KM: Complete sequence of Enterococcus faecium pVEF3 and the detection of an omega-epsilon-zeta toxin-antitoxin module and an ABC transporter. Plasmid 2008, 60:75-85.
239. van den Braak N, van Belkum A, van Keulen M, Vliegenthart J, Verbrugh HA, Endtz HP: Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands. J Clin Microbiol 1998, 36:1927-1932.
240. Werner G, Freitas AR, Coque TM, Sollid JE, Lester C, Hammerum AM, Garcia-Migura L, Jensen LB, Francia MV, Witte W et al.: Host range of enterococcal vanA plasmids among Gram-positive intestinal bacteria. J Antimicrob Chemother 2011, 66:273-282.
241. Lester CH, Hammerum AM: Transfer of vanA from an Enterococcus faecium isolate of chicken origin to a CC17 E. faecium isolate in the intestine of cephalosporin-treated mice. J Antimicrob Chemother 2010, 65:1534-1536.
242. Lester CH, Frimodt-Moller N, Sorensen TL, Monnet DL, Hammerum AM: In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother 2006, 50:596-599.
243. Moubareck C, Bourgeois N, Courvalin P, Doucet-Populaire F: Multiple antibiotic resistance gene transfer from animal to human enterococci in the digestive tract of gnotobiotic mice. Antimicrob Agents Chemother 2003, 47:2993-2996.
244. Dahl KH, Mater DD, Flores MJ, Johnsen PJ, Midtvedt T, Corthier G, Sundsfjord A: Transfer of plasmid and chromosomal glycopeptide resistance determinants occurs more readily in the digestive tract of mice than in vitro and exconjugants can persist stably in vivo in the absence of glycopeptide selection. J Antimicrob Chemother 2007, 59:478-486.
245. Willems RJ, Top J, van Den BN, van BA, Mevius DJ, Hendriks G, van Santen-Verheuvel M, Van Embden JD: Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 1999, 43:483-491.
246. Huh JY, Lee WG, Lee K, Shin WS, Yoo JH: Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. J Clin Microbiol 2004, 42:1897-1902.
247. Jung WK, Lim JY, Kwon NH, Kim JM, Hong SK, Koo HC, Kim SH, Park YH: Vancomycin-resistant enterococci from animal sources in Korea. Int J Food Microbiol 2007, 113:102-107.
248. Jensen LB, Ahrens P, Dons L, Jones RN, Hammerum AM, Aarestrup FM: Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol 1998, 36:437-442.
249. Hegstad K, Mikalsen T, Coque TM, Werner G, Sundsfjord A: Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococus faecium. Clin Microbiol Infect 2010, 16:541-554.
250. Stinear TP, Olden DC, Johnson PD, Davies JK, Grayson ML: Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. The Lancet 2001, 357:855-856.
251. Hershberger E, Oprea SF, Donabedian SM, Perri M, Bozigar P, Bartlett P, Zervos MJ: Epidemiology of antimicrobial resistance in enterococci of animal origin. J Antimicrob Chemother 2005, 55:127-130.
252. Poole TL, Hume ME, Campbell LD, Scott HM, Alali WQ, Harvey RB: Vancomycinresistant Enterococcus faecium strains isolated from community wastewater from a semiclosed agri-food system in Texas. Antimicrob Agents Chemother 2005, 49:4382-4385.
253. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson K, Leclerq R, Lester CH et al.: Emergence and spread of vancomycin resistance among enterococci in Europe. EuroSurveillance 2008, 13:pii: 19046.
254. Devriese LA: In vitro susceptibility and resistance of animal staphylococci to macrolide antibiotics and related compounds. Ann Rech Vet 1976, 7:65-74.
255. Dublanchet A, Soussy CJ, Squinazi F, Duval J: [Resistance to streptogramin antibiotics in “Staphylococcus aureus” (author’s transl)]. Ann Microbiol (Paris) 1977, 128A:277-287.
256. Rende-Fournier R, Leclercq R, Galimand M, Duval J, Courvalin P: Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrob Agents Chemother 1993, 37:2119-2125.
257. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J: Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother 1999, 43:1062-1066.
258. Loncle V, Casetta A, Buu-Hoi A, El SN: Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates responsible for an outbreak in a Parisian hospital. Antimicrob Agents Chemother 1993, 37:2159-2165.
259. Werner G, Cuny C, Schmitz FJ, Witte W: Methicillin-resistant, quinupristindalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides. J Clin Microbiol 2001, 39:3586-3590.
260. Hammerum AM, Jensen LB, Aarestrup FM: Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals. FEMS Microbiol Lett 1998, 168:145-151.
261. Welton LA, Thal LA, Perri MB, Donabedian S, McMahon J, Chow JW, Zervos MJ: Antimicrobial resistance in enterococci isolated from turkey flocks fed virginiamycin. Antimicrob Agents Chemother 1998, 42:705-708.
262. Werner G, Hildebrandt B, Klare I, Witte W: Linkage of determinants for streptogramin A, macrolide-lincosamide-streptogramin B, and chloramphenicol resistance on a conjugative plasmid in Enterococcus faecium and dissemination of this cluster among streptogramin-resistant enterococci. Int J Med Microbiol 2000, 290:543-548.
263. Van Den Bogaard AE, London N, Stobberingh EE: Antimicrobial resistance in pig faecal samples from the Netherlands (five abattoirs) and Sweden. J Antimicrob Chemother 2000, 45:663-671.
264. Jensen LB, Hammerum AM, Aerestrup FM, Van Den Bogaard AE, Stobberingh EE: Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands. Antimicrob Agents Chemother 1998, 42:3330-3331.
265. Haroche J, Allignet J, Aubert S, Van Den Bogaard AE, El SN: satG, conferring resistance to streptogramin A, is widely distributed in Enterococcus faecium strains but not in staphylococci. Antimicrob Agents Chemother 2000, 44:190-191.
266. Allignet J, El SN: Comparative analysis of staphylococcal plasmids carrying three streptogramin-resistance genes: vat-vgb-vga. Plasmid 1999, 42:134-138.
267. Soltani M, Beighton D, Philpott-Howard J, Woodford N: Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe. Antimicrob Agents Chemother 2000, 44:433-436.
268. McDonald LC, Rossiter S, Mackinson C, Wang YY, Johnson S, Sullivan M, Sokolow R, DeBess E, Gilbert L, Benson JA et al.: Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med 2001, 345:1155-1160.
269. Hayes JR, Wagner DD, English LL, Carr LE, Joseph SW: Distribution of streptogramin resistance determinants among Enterococcus faecium from a poultry production environment of the USA. J Antimicrob Chemother 2005, 55:123-126.
270. Hayes JR, English LL, Carr LE, Wagner DD, Joseph SW: Multiple-antibiotic resistance of Enterococcus spp. isolated from commercial poultry production environments. Appl Environ Microbiol 2004, 70:6005-6011.
271. Hammerum AM, Agers Y, Garcia-Migura L, Mette Seyfarth A, Porsbo LJ, Emborg HD, Bog° Jensen L: Evaluation of the quinupristin/dalfopristin breakpoints for Enterococcus faecium. International Journal of Antimicrobial Agents 2009, 34:288-290.
272. Simjee S, White DG, Meng J, Wagner DD, Qaiyumi S, Zhao S, Hayes JR, McDermott PF: Prevalence of streptogramin resistance genes among Enterococcus isolates recovered from retail meats in the Greater Washington DC area. J Antimicrob Chemother 2002, 50:877-882.
273. Jackson CR, Fedorka-Cray PJ, Barrett JB, Hiott LM, Woodley TA: Prevalence of streptogramin resistance in enterococci from animals: identification of vatD from animal sources in the USA. International Journal of Antimicrobial Agents 2007, 30:60-66.
274. Donabedian SM, Perri MB, Vager D, Hershberger E, Malani P, Simjee S, Chow J, Vergis EN, Muder RR, Gay K et al.: Quinupristin-dalfopristin resistance in Enterococcus faecium Isolates from humans, farm animals, and grocery store meat in the United States. J Clin Microbiol 2006, 44:3361-3365.
275. Hwang IY, Ku HO, Lim SK, Lee KJ, Park CK, Jung GS, Jung SC, Park YH, Nam HM: Distribution of streptogramin resistance genes and genetic relatedness among quinupristin/dalfopristin-resistant Enterococcus faecium recovered from pigs and chickens in Korea. Res Vet Sci 2010, 89:1-4.
276. Luh KT, Hsueh PR, Teng LJ, Pan HJ, Chen YC, Lu JJ, Wu JJ, Ho SW: Quinupristindalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob Agents Chemother 2000, 44:3374-3380.
277. Oh WS, Ko KS, Song JH, Lee MY, Park S, Peck KR, Lee NY, Kim CK, Lee H, Kim SW et al.: High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea. Antimicrob Agents Chemother 2005, 49:5176-5178.
278. McDermott PF, Cullen P, Hubert SK, McDermott SD, Bartholomew M, Simjee S, Wagner DD: Changes in antimicrobial susceptibility of native Enterococcus faecium in chickens fed virginiamycin. Appl Environ Microbiol 2005, 71:4986-4991.
279. Jensen LB, Hammerum AM, Aarestrup FM: Linkage of vat(E) and erm(B) in streptogamin-resistant Enterococcus faecium isolates from Europe. Antimicrob Agents Chemother 2000, 44:2231-2232.
280. Hammerum AM, Flannagan SE, Clewell DB, Jensen LB: Indication of transposition of a mobile DNA element containing the vat(D) and erm(B) genes in Enterococcus faecium. Antimicrob Agents Chemother 2001, 45:3223-3225.
281. Jacobsen BL, Skou M, Hammerum AM, Jensen LB: Horizontal transfer of the satA gene encoding streptogramin A resistance between isogenic Enterococcus faecium strains in the gastrointestinal tract of gnotobiotic rats. Microbial Ecology in Health and Disease 1999, 11:241-247.
282. Heuer, O.E., Agerso Y, Embourg H-D, Seyfarth AM, Jensen US, Hammerum AM, Muller A, Skov RL, Monnet D: DANMAP 2006. Copenhagen: Schultz Grafisk A/S, DK; 2007.
283. Top J, Willems R, Bonten M: Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 2008, 52:297-308.
284. Jung WK, Hong SK, Lim JY, Lim SK, Kwon NH, Kim JM, Koo HC, Kim SH, Seo KS, Ike Y et al.: Phenotypic and genetic characterization of vancomycin-resistant enterococci from hospitalized humans and from poultry in Korea. FEMS Microbiol Lett 2006, 260:193-200.
285. Nam HM, Lim SK, Moon JS, Kang HM, Kim JM, Jang KC, Kim JM, Kang MI, Joo YS, Jung SC: Antimicrobial resistance of enterococci isolated from mastitic bovine milk samples in Korea. Zoonoses Public Health 2009.
286. Herrero IA, Issa NC, Patel R: Nosocomial spread of linezolid-resistant, vancomycinresistant Enterococcus faecium. N Engl J Med 2002, 346:867-869.
287. Dobbs TE, Patel M, Waites KB, Moser SA, Stamm AM, Hoesley CJ: Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center. J Clin Microbiol 2006, 44:3368-3370.
288. Anderegg TR, Sader HS, Fritsche TR, Ross JE, Jones RN: Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program. Int J Antimicrob Agents 2005, 26:13-21.
289. Ross JE, Anderegg TR, Sader HS, Fritsche TR, Jones RN: Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program. Diagn Microbiol Infect Dis 2005, 52:53-58.
290. Biedenbach DJ, Farrell DJ, Mendes RE, Ross JE, Jones RN: Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox(R) Annual Appraisal of Potency and Spectrum program. Diagn Microbiol Infect Dis 2010, 68:459-467.
291. Jones RN, Ross JE, Bell JM, Utsuki U, Fumiaki I, Kobayashi I, Turnidge JD: Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008. Diagn Microbiol Infect Dis 2009, 65:404-413.
292. Tenover FC: Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis 2001, 33 Suppl 3:S108-S115.
293. Li Y, Tomita H, Lv Y, Liu J, Xue F, Zheng B, Ike Y: Molecular characterization of erm(B)-and mef(E)-mediated erythromycin-resistant Streptococcus pneumoniae in China and complete DNA sequence of Tn2010. J Appl Microbiol 2011, 110:254-265.
294. Heuer OE, Pedersen K, Jensen LB, Madsen M, Olsen JE: Persistence of vancomycinresistant enterococci (VRE) in broiler houses after the avoparcin ban. Microb Drug Resist 2002, 8:355-361.
295. Maki T, Santos MD, Kondo H, Hirono I, Aoki T: A transferable 20-kilobase multiple drug resistance-conferring R plasmid (pKL0018) from a fish pathogen (Lactococcus garvieae) is highly homologous to a conjugative multiple drug resistance-conferring enterococcal plasmid. Appl Environ Microbiol 2009, 75:3370-3372.
296. Cauwerts K, Decostere A, De Graef EM, Haesebrouck F, Pasmans F: High prevalence of tetracycline resistance in Enterococcus isolates from broilers carrying the erm(B) gene. Avian Pathol 2007, 36:395-399.
297. Schwaiger K, Harms K, Holzel C, Meyer K, Karl M, Bauer J: Tetracycline in liquid manure selects for co-occurrence of the resistance genes tet(M) and tet(L) in Enterococcus faecalis. Vet Microbiol 2009, 139:386-392.
298. Weigel LM, Donlan RM, Shin DH, Jensen B, Clark NC, McDougal LK, Zhu W, Musser KA, Thompson J, Kohlerschmidt D et al.: High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 2007, 51:231-238.
299. Woodford N, Morrison D, Cookson B, George RC: Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents. Antimicrob Agents Chemother 1993, 37:681-684.
300. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR: Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med 1987, 106:687-691.
301. Saeedi B, Hallgren A, Isaksson B, Jonasson J, Nilsson LE, Hanberger H: Genetic relatedness of Enterococcus faecalis isolates with high-level gentamicin resistance from patients with bacteraemia in the south east of Sweden 1994-2001. Scand J Infect Dis 2004, 36:405-409.
302. Simjee S, Manzoor SE, Fraise AP, Gill MJ: Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United Kingdom. J Antimicrob Chemother 2000, 45:565-575.
303. Qu TT, Chen YG, Yu YS, Wei ZQ, Zhou ZH, Li LJ: Genotypic diversity and epidemiology of high-level gentamicin resistant Enterococcus in a Chinese hospital. J Infect 2006, 52:124-130.
304. Chan YY, bd Nasir MH, Yahaya MA, Salleh NM, Md Dan AD, Musa AM, Ravichandran M: Low prevalence of vancomycin-and bifunctional aminoglycosideresistant enterococci isolated from poultry farms in Malaysia. Int J Food Microbiol 2008, 122:221-226.
305. Petsaris O, Miszczak F, Gicquel-Bruneau M, Perrin-Guyomard A, Humbert F, Sanders P, Leclercq R: Combined antimicrobial resistance in Enterococcus faecium isolated from chickens. Appl Environ Microbiol 2005, 71:2796-2799.
306. Jackson CR, Fedorka-Cray PJ, Barrett JB, Ladely SR: High-level aminoglycoside resistant enterococci isolated from swine. Epidemiol Infect 2005, 133:367-371.
307. Donabedian SM, Thal LA, Hershberger E, Perri MB, Chow JW, Bartlett P, Jones R, Joyce K, Rossiter S, Gay K et al.: Molecular characterization of gentamicin-resistant Enterococci in the United States: evidence of spread from animals to humans through food. J Clin Microbiol 2003, 41:1109-1113.
308. Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F et al.: vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 2010, 54:4643-4647.